Statistics for Castle Biosciences (id:6515 CSTL)

Valuation metrics

Market cap

863.47M

Enterprise value

637.59M

Trailing P/E (ttm)

146.81

Forward P/E

-15.19

PEG ratio

-15.19

Price/Sales (ttm)

2.77

Price/Book (mrq)

1.96

Enterprise Value/Revenue

2.04

Enterprise Value/EBITDA

51.36

Overview

Shares outstanding

28.01M

Float

27.21M

Shares short

1.61M

% Held by insiders

0.03%

% Held by institutions

0.97%

Average volume (10 days)

546.25K

Average volume (90 days)

Price summary

52-Week low

16.96

52-Week high

35.84

52-Week change

30.23%

Beta

0.98

50-Day moving average

31.13

200-Day moving average

24.81

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

1.95%

Operating margin

5.92%

Operational effectiveness

Return on assets

-0.14%

Return on equity

1.47%

Income statement

Revenue (ttm)

11.34

Revenue per share (ttm)

11.34

Quarterly revenue growth (yoy)

Gross profit (ttm)

174.81M

EBITDA

25.08M

Net income to common (ttm)

6.08M

Diluted EPS (ttm)

0.21

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

279.78M

Total cash per share (mrq)

9.99

Total debt (mrq)

26.74M

Total Debt/Equity (mrq)

6.06

Current ratio (mrq)

778.40%

Book value per share (mrq)

15.77

Cash flow

Cash flow statement

59.09M

Levered free cash flow (LFCF)

30.83M